XML 75 R63.htm IDEA: XBRL DOCUMENT v3.7.0.1
Other Arrangements (Details) - USD ($)
12 Months Ended
Dec. 31, 2008
Jun. 30, 2017
Other Income and Expenses [Abstract]    
Gross proceeds from sale of royalty rights receivable from GlaxoSmithKline $ 160,000,000.0  
Deferred revenue royalty purchase agreement   $ 9,600,000